Levetiracetam Brillpharma

Levetiracetam, the active ingredient in Levetiracetam Brillpharma, is an anticonvulsant presented as a tablet in various strengths for oral use. It treats partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Brillpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug indicated for several seizure types: - Partial‑onset seizures: reduces frequency of focal seizures in adults and children. - Generalized tonic‑clonic seizures: helps control convulsive episodes across age groups. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach or urge to vomit. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: low white blood cells or platelets. - Liver dysfunction: jaundice or elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures: - Renal function: assess kidney performance and adjust dose if impairment is present. - Hepatic status: monitor liver enzymes in patients with liver disease. - Psychiatric history: watch for mood alterations, especially in those with prior depression or anxiety. - Concomitant CNS depressants: avoid excessive sedation when combined with other central nervous system depressants. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing seizure control. - Phenobarbital: can lower levetiracetam concentrations, risking breakthrough seizures.

Moderate Interactions (Monitor Closely): - Oral contraceptives: levetiracetam may diminish hormonal contraceptive effectiveness. - Sedative agents (e.g., benzodiazepines): additive CNS depression may occur. - Antidepressants: monitor for increased irritability or mood changes. - Immunosuppressants: observe for altered drug levels, especially in transplant patients.